Healthcare & Life Sciences
Orbus Therapeutics
series-a
series-a
Stage
1
Investors
About
Orbus Therapeutics is developing therapeutics targeting rare cancers, including anaplastic astrocytoma.
Explore Orbus Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.